FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994950221> ?p ?o ?g. }

• W1994950221 endingPage "169" @default.
• W1994950221 startingPage "160" @default.
• W1994950221 abstract "Tumor hypoxia is a major cause of treatment failure for a variety of malignancies. However, tumor hypoxia also offers treatment opportunities, exemplified by the development compounds that target hypoxic regions within tumors. TH-302 is a pro-drug created by the conjugation of 2-nitroimidazole to bromo-isophosphoramide (Br-IPM). When TH-302 is delivered to regions of hypoxia, Br-IPM, the DNA cross linking toxin, is released. In this study we assessed the cytotoxic activity of TH-302 against osteosarcoma cells in vitro and evaluated its anticancer efficacy as a single agent, and in combination with doxorubicin, in an orthotopic mouse model of human osteosarcoma (OS). In vitro, TH-302 was potently cytotoxic to osteosarcoma cells selectively under hypoxic conditions, whereas primary normal human osteoblasts were protected. Animals transplanted with OS cells directly into their tibiae and left untreated developed mixed osteolytic/osteosclerotic bone lesions and subsequently developed lung metastases. TH-302 reduced tumor burden in bone and cooperated with doxorubicin to protect bone from osteosarcoma induced bone destruction, while it also reduced lung metastases. TH-302 may therefore be an attractive therapeutic agent with strong activity as a single agent and in combination with chemotherapy against OS." @default.
• W1994950221 created "2016-06-24" @default.
• W1994950221 creator A5003751848 @default.
• W1994950221 creator A5011048271 @default.
• W1994950221 creator A5011750139 @default.
• W1994950221 creator A5011783424 @default.
• W1994950221 creator A5013717439 @default.
• W1994950221 creator A5020115349 @default.
• W1994950221 creator A5051520123 @default.
• W1994950221 creator A5060420333 @default.
• W1994950221 creator A5060765287 @default.
• W1994950221 creator A5063525056 @default.
• W1994950221 creator A5065929346 @default.
• W1994950221 creator A5075623882 @default.
• W1994950221 date "2015-02-01" @default.
• W1994950221 modified "2023-09-25" @default.
• W1994950221 title "Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma" @default.
• W1994950221 cites W1561977930 @default.
• W1994950221 cites W1870008296 @default.
• W1994950221 cites W1893064691 @default.
• W1994950221 cites W1995341351 @default.
• W1994950221 cites W1996543107 @default.
• W1994950221 cites W1999660608 @default.
• W1994950221 cites W2000850920 @default.
• W1994950221 cites W2001544310 @default.
• W1994950221 cites W2003670869 @default.
• W1994950221 cites W2028006541 @default.
• W1994950221 cites W2029206767 @default.
• W1994950221 cites W2031188419 @default.
• W1994950221 cites W2034072253 @default.
• W1994950221 cites W2039686677 @default.
• W1994950221 cites W2046945256 @default.
• W1994950221 cites W2057895959 @default.
• W1994950221 cites W2063025597 @default.
• W1994950221 cites W2082594665 @default.
• W1994950221 cites W2085450504 @default.
• W1994950221 cites W2087324367 @default.
• W1994950221 cites W2087565365 @default.
• W1994950221 cites W2091940240 @default.
• W1994950221 cites W2104928951 @default.
• W1994950221 cites W2110653270 @default.
• W1994950221 cites W2151029652 @default.
• W1994950221 cites W2154783588 @default.
• W1994950221 cites W2158132138 @default.
• W1994950221 cites W2160486862 @default.
• W1994950221 cites W2169795422 @default.
• W1994950221 cites W2172236291 @default.
• W1994950221 cites W4253290623 @default.
• W1994950221 doi "https://doi.org/10.1016/j.canlet.2014.11.020" @default.
• W1994950221 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4574867" @default.
• W1994950221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25444931" @default.
• W1994950221 hasPublicationYear "2015" @default.
• W1994950221 type Work @default.
• W1994950221 sameAs 1994950221 @default.
• W1994950221 citedByCount "42" @default.
• W1994950221 countsByYear W19949502212016 @default.
• W1994950221 countsByYear W19949502212017 @default.
• W1994950221 countsByYear W19949502212018 @default.
• W1994950221 countsByYear W19949502212019 @default.
• W1994950221 countsByYear W19949502212020 @default.
• W1994950221 countsByYear W19949502212021 @default.
• W1994950221 countsByYear W19949502212022 @default.
• W1994950221 crossrefType "journal-article" @default.
• W1994950221 hasAuthorship W1994950221A5003751848 @default.
• W1994950221 hasAuthorship W1994950221A5011048271 @default.
• W1994950221 hasAuthorship W1994950221A5011750139 @default.
• W1994950221 hasAuthorship W1994950221A5011783424 @default.
• W1994950221 hasAuthorship W1994950221A5013717439 @default.
• W1994950221 hasAuthorship W1994950221A5020115349 @default.
• W1994950221 hasAuthorship W1994950221A5051520123 @default.
• W1994950221 hasAuthorship W1994950221A5060420333 @default.
• W1994950221 hasAuthorship W1994950221A5060765287 @default.
• W1994950221 hasAuthorship W1994950221A5063525056 @default.
• W1994950221 hasAuthorship W1994950221A5065929346 @default.
• W1994950221 hasAuthorship W1994950221A5075623882 @default.
• W1994950221 hasBestOaLocation W19949502212 @default.
• W1994950221 hasConcept C126322002 @default.
• W1994950221 hasConcept C142724271 @default.
• W1994950221 hasConcept C154317977 @default.
• W1994950221 hasConcept C178790620 @default.
• W1994950221 hasConcept C185592680 @default.
• W1994950221 hasConcept C202751555 @default.
• W1994950221 hasConcept C203014093 @default.
• W1994950221 hasConcept C2776035513 @default.
• W1994950221 hasConcept C2776694085 @default.
• W1994950221 hasConcept C2777714996 @default.
• W1994950221 hasConcept C2777760704 @default.
• W1994950221 hasConcept C2780035454 @default.
• W1994950221 hasConcept C2781303535 @default.
• W1994950221 hasConcept C502942594 @default.
• W1994950221 hasConcept C540031477 @default.
• W1994950221 hasConcept C55493867 @default.
• W1994950221 hasConcept C71924100 @default.
• W1994950221 hasConcept C7836513 @default.
• W1994950221 hasConcept C86803240 @default.
• W1994950221 hasConcept C98274493 @default.
• W1994950221 hasConceptScore W1994950221C126322002 @default.
• W1994950221 hasConceptScore W1994950221C142724271 @default.

• next